# Proton Pump Inhibitor Prevent Dual Antiplatelet Agents Induced Gastrointestinal Ulcer After Coronary Artery Bypass Graft

> **NCT03038009** · PHASE4 · WITHDRAWN · sponsor: **Ruijin Hospital**

## Conditions studied

- Gastric Ulcer Induced by Antiplatelet Agent
- Ulcer of the Gastrointestinal Tract
- Proton Pump Inhibitor

## Interventions

- **DRUG:** Pantoprazole

## Key facts

- **NCT ID:** NCT03038009
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-10
- **Primary completion:** 2020-09
- **Final completion:** 2020-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** A new registration has been submitted due to a redesign of the study protocol.
- **Last updated:** 2019-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03038009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03038009, "Proton Pump Inhibitor Prevent Dual Antiplatelet Agents Induced Gastrointestinal Ulcer After Coronary Artery Bypass Graft". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03038009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*